FIELD: medicine.
SUBSTANCE: inhalable composition comprising: nicotine or a pharmaceutically acceptable derivative thereof or a salt thereof; propellant gas; monohydric alcohol; and glycol and / or glycol ether, wherein the ratio of monohydric alcohol: glycol or glycol ether by weight is in the range of 3:1 to 1:1.
EFFECT: composition administered by oral inhalation is capable of mimicking the pharmacokinetic profile of a conventional cigarette, and is therefore particularly effective for use in nicotine replacement therapy.
34 cl, 4 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CARBONATED LIQUID FOR ELECTRONIC CIGARETTES | 2022 |
|
RU2782648C1 |
| NICOTINE EDIBLE PAPER | 2019 |
|
RU2745039C1 |
| NICOTINE COMPOSITION FOR PERORAL APPLICATION, WHICH CONTAINS AMINO-ACID BUFFER | 2008 |
|
RU2465904C2 |
| INHALED NICOTINIC COMPOSITIONS AND METHODS FOR PREPARATION AND USE THEREOF | 2016 |
|
RU2719228C2 |
| BUFFERED LIQUID NICOTINE COMPOSITION FOR PULMONARY ADMINISTRATION | 2003 |
|
RU2283111C2 |
| NICOTINE COMPOUNDS AND METHODS FOR PREPARING AND USING THEM | 2016 |
|
RU2722446C2 |
| PHARMACEUTICAL PRODUCT FOR INTRAORAL NICOTINE ADMINISTRATION CONTAINING TROMETAMOL AS BUFFER AGENT | 2007 |
|
RU2436566C2 |
| LIQUID PHARMACEUTICAL COMPOSITION COMPRISING NICOTINE FOR ADMINISTRATION INTO MOUTH CAVITY | 2002 |
|
RU2279871C2 |
| CHEWING GUM WITH NICOTINE | 2019 |
|
RU2793690C2 |
| SOLID NICOTINE-CONTAINING DOSAGE FORM WITH REDUCED UNPLEASANT ORGANOLEPTIC IMPACT | 2013 |
|
RU2623018C2 |
